![David Giljohann](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Giljohann
Directeur Général chez
EVOQ Therapeutics, Inc.
Profil
David A. Giljohann is Chief Executive Officer at EVOQ Therapeutics, Inc. since 2023.
Former roles include Founding Scientist at Aurasense LLC, Chief Operating Officer & Principal Scientist at Exicure Operating Co. from 2012 to 2013, and Chief Technology Officer at Exicure, Inc. from 2021 to 2022.
Education includes undergraduate and doctorate degrees from Northwestern University.
Postes actifs de David Giljohann
| Sociétés | Poste | Début |
|---|---|---|
EVOQ Therapeutics, Inc.
 EVOQ Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in developing new vaccine strategies for improving outcomes for cancer patients | Directeur Général | 01/01/2023 |
Anciens postes connus de David Giljohann
| Sociétés | Poste | Fin |
|---|---|---|
| EXICURE, INC. | Directeur Général | 10/12/2021 |
Aurasense LLC
 Aurasense LLC BiotechnologyHealth Technology Engages in advanced nanotechnology solutions | Directeur Technique/Scientifique/R&D | 01/01/2009 |
Exicure Operating Co.
 Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Develops immunomodulatory and gene regulating drugs | Directeur Général | - |
Formation de David Giljohann
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
4
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Aurasense LLC
Aurasense LLC BiotechnologyHealth Technology Engages in advanced nanotechnology solutions | Health Technology |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Exicure Operating Co.
Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Develops immunomodulatory and gene regulating drugs | Health Technology |
Exicure, Inc.
 Exicure, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops nucleic acid therapies against to neurological disorders and hair loss | Health Technology |
EVOQ Therapeutics, Inc.
EVOQ Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in developing new vaccine strategies for improving outcomes for cancer patients | Health Technology |
Choisissez Zonebourse 
